Revenue Insights: Walgreens Boots Alliance, Inc. and Grifols, S.A. Performance Compared

Comparing revenue growth of Walgreens and Grifols over a decade.

__timestampGrifols, S.A.Walgreens Boots Alliance, Inc.
Wednesday, January 1, 2014335538400076392000000
Thursday, January 1, 20153934563000103444000000
Friday, January 1, 20164049830000117351000000
Sunday, January 1, 20174318073000118214000000
Monday, January 1, 20184486724000131537000000
Tuesday, January 1, 20195098691000120074000000
Wednesday, January 1, 20205340038000121982000000
Friday, January 1, 20214933118000132509000000
Saturday, January 1, 20226063967000132703000000
Sunday, January 1, 20236591977000139081000000
Monday, January 1, 2024147658000000
Loading chart...

Unleashing insights

Revenue Growth: Walgreens Boots Alliance vs. Grifols

In the ever-evolving landscape of global healthcare, Walgreens Boots Alliance, Inc. and Grifols, S.A. stand as significant players. Over the past decade, Walgreens Boots Alliance has consistently outperformed Grifols in terms of revenue, showcasing a robust growth trajectory. From 2014 to 2023, Walgreens Boots Alliance's revenue surged by approximately 82%, reaching a peak in 2023. In contrast, Grifols experienced a more modest growth of around 97% over the same period, reflecting its steady expansion in the pharmaceutical sector.

Despite the impressive growth, 2024 data for Grifols remains unavailable, leaving a gap in the comparative analysis. This missing data highlights the dynamic nature of the industry and the challenges in maintaining consistent growth. As these companies continue to navigate the complexities of the healthcare market, their revenue trends offer valuable insights into their strategic directions and market positions.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025